US EditionBiogen (NASDAQ:BIIB) Given New $225.00 Price Target at Royal Bank of Canada
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
Biogen (NASDAQ:BIIB) Given New $225.00 Price Target at Royal Bank of Canada
Biogen (NASDAQ:BIIB – Free Report) had its price target lifted by Royal Bank of Canada from $221.00 to $225.00 in a report released on Tuesday,Benzinga reports. Royal Bank of Canada currently has an outperform rating on the biotechnology company’s stock. A number of other brokerages have also weighed in on BIIB. Wells Fargo & Company […]
Royal Bank of Canada Cuts Open Text (NASDAQ:OTEX) Price Target to $30.00
Open Text (NASDAQ:OTEX – Free Report) (TSE:OTC) had its price objective cut by Royal Bank of Canada from $31.00 to $30.00 in a research note issued to investors on Tuesday,BayStreet.CA reports. They currently have a sector perform rating on the software maker’s stock. A number of other equities analysts have also weighed in on OTEX. […]
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
